NCT04752267 - 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

September 18, 2023

Study Completion Date

September 18, 2023

Conditions

Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8GliomaMalignant Brain NeoplasmMetastatic Breast CarcinomaMetastatic Colon CarcinomaMetastatic Kidney CarcinomaMetastatic Lung CarcinomaMetastatic Malignant Neoplasm in the BrainMetastatic MelanomaPathologic Stage IV Cutaneous Melanoma AJCC v8Prognostic Stage IV Breast Cancer AJCC v8Stage IV Colon Cancer AJCC v8Stage IV Lung Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8Stage IVA Colon Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Colon Cancer AJCC v8Stage IVB Lung Cancer AJCC v8Stage IVC Colon Cancer AJCC v8

Interventions

PROCEDURE

Computed Tomography

Undergo PET/CT

DRUG

18F-FMAU

Given IV

PROCEDURE

Multiparametric Magnetic Resonance Imaging

Undergo mpMRI

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

Trial Locations (1)

90033

USC / Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER